HerDesire.net CME Initiative

agement of HSDD. Define and differentiate between Female Sexual Disorder (FSD) and HSDD through careful use of screening questionnaires, assessment, and physical examination, to ensure proper diagnosis and successful non-medical and medical treatment outcomes

2. Recognize the level of distress HSDD and sexual dysfunction have on each patient’s overall health and well-being

3. Encourage each woman to engage in discussions of sexual health with her doctor, to determine “normal” sexual function and dysfunction for her

4. Select appropriate treatment based on available FDA-approved treatment options, patient’s treatment goals, and the degree to which the patient wants sexual function restored

5. Evaluate and proactively manage Adverse Events (AEs) of HSDD medications and modalities to allay patient concerns about side effects and ensure therapeutic persistence

INTENDED AUDIENCE:

Ob-Gyns, primary care clinicians, endocrinologists, nurses with focus in reproductive/sexual medicine, NPs/PAs, psychologists/sex therapists, urologists, residents/fellows of above disciplines, managed care clinicians, and clinical pharmacists interested in management and treatment of HSDD.